Previous studies have shown that assessment of immunoglobulin subclasses in plasma cells by immunohistochemistry (IHC) may be useful in the histopathologic evaluation of autoimmune liver diseases.

By Vermeulen, Nathalie Arijs, Ingrid; Joossens, Sofie; Vermeire, Severine; Clerens, Stefan; Van den Bergh, Karolien; Michiels, Georges; Arckens, Lutgarde; Schuit, Frans; Van Lommel, Leentje; Rutgeerts, Paul; Bossuyt, Xavier BACKGROUND: Patients with inflammatory bowel disease (IBD) carry autoantibodies such as perinuclear antineutrophil cytoplasmic antibodies (pANCA).

LifeCycle Pharma has initiated a Phase II clinical trial of LCP-Tacro for the treatment of autoimmune hepatitis, a disease which causes a person's body to reject its own liver.

LifeCycle Pharma A/S (OMX:LCP) (the "Company" or

By Chang, Ming-Chu Chang, Yu-Ting; Tien, Yu-Wen; Liang, Po-Chin; Et al Background: Autoimmune pancreatitis (AIP) is a distinct disease entity of chronic pancreatitis.